Recent News News Blog Press Releases In the News Featured News Publications Contact Us Press Release Sep. 22, 2021 Wistar and Penn Medicine Awarded $11.7 Million Melanoma Research G... PHILADELPHIA — (Sept. Press Release Sep. 21, 2021 Wistar Scientists Identify New Therapeutic Target in Ovarian Cance... Ovarian clear cell carcinomas with ARID1A mutations are sensitive to inhibition of the IRE1a-XBP1 stress response pathway in preclinical models. Blog Post Sep. 15, 2021 Dr. Hildegund Ertl Vaccine Thought Leader and Formidable Presence A seasoned scientist lends her expert voice against vaccine hesitancy. Blog Post Sep. 15, 2021 Dr. Noam Auslander: New Faculty Addition Brings Artificial Intelli... Wistar welcomes Dr. Noam Auslander as an assistant professor in the Cancer Center’s Molecular & Cellular Oncogenesis Program. She applies artificial intelligence (AI) through high-throughput… Blog Post Sep. 8, 2021 Viruses and Cancer Viruses impact human health in many ways and can be the underlying agents that cause cancer. Blog Post Sep. 3, 2021 Expanding the Caspar Wistar Fellows Program The Caspar Wistar Fellowship is a model for recruiting the best and brightest junior scientists to Wistar where they can build scientific networks and advance their unique independent research… Press Release Sep. 1, 2021 The Wistar Institute Recruits Vaccine Researcher Amelia Escolano, ... PHILADELPHIA — (Sept. 1, 2021) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, welcomes Amelia Escolano, Ph.D., and Nan Zhang, Ph… Press Release Aug. 31, 2021 The Wistar Institute Appoints Italo Tempera, Ph.D., as Associate D... PHILADELPHIA — (Aug. 31, 2021) — The Wistar Institute announces the appointment of Italo Tempera, Ph.D., as Associate Director for Cancer Research Career Enhancement at the Institute’s Cancer… Press Release Aug. 25, 2021 Wistar Scientists Unveil Widespread Tumor Suppression Mechanism Parkin tumor suppressor blocks tumor growth and invasion by inhibiting metabolic reprogramming and mitochondrial function. Press Release Aug. 17, 2021 The BEAT-HIV Collaboratory Receives More Than $29 Million in NIH F... The collaboratory led by Wistar investigators will continue to test novel combined immunotherapies to advance research towards a cure for HIV. Blog Post Aug. 16, 2021 Congratulations BTT Program and BRT Apprenticeship Graduates! On August 12, Wistar hosted a ceremony for the Biomedical Technician Training (BTT) Program graduates of 2020 and 2021 and the Biomedical Research Technician (BRT) Apprenticeship graduates of 2021… Press Release Jul. 30, 2021 The Wistar Institute Recruits Daniel Claiborne, Ph.D., as Caspar W... PHILADELPHIA — (July 30, 2021) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of… Communications In the News Check out some of the recent media coverage Wistar and its scientists have received. Publications View our Annual Report, Focus magazine and sign-up for our monthly e-newsletter. Media Inquiries If you are a member of the media and would like to speak with a Wistar scientists on any matter, please contact our Communications and Marketing Department.
